Cargando…
Imaging asparaginyl endopeptidase (AEP) in the live brain as a biomarker for Alzheimer’s disease
BACKGROUND: Discovery of early-stage biomarkers is a long-sought goal of Alzheimer’s disease (AD) diagnosis. Age is the greatest risk factor for most AD and accumulating evidence suggests that age-dependent elevation of asparaginyl endopeptidase (AEP) in the brain may represent a new biological mark...
Autores principales: | Wang, Shan-Shan, Liu, Zi-Kai, Liu, Jing-Jing, Cheng, Qing, Wang, Yan-Xia, Liu, Yan, Ni, Wen-Wen, Chen, Hong-Zhuan, Song, Mingke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375181/ https://www.ncbi.nlm.nih.gov/pubmed/34412639 http://dx.doi.org/10.1186/s12951-021-00988-0 |
Ejemplares similares
-
Pharmacological Inhibition of the Asparaginyl Endopeptidase (AEP) in an Alzheimer’s Disease Model Improves the Survival and Efficacy of Transplanted Neural Stem Cells
por: Cheng, Qing, et al.
Publicado: (2023) -
Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer’s disease-related pathologies in a senescence-accelerated mouse model
por: Wang, Ju, et al.
Publicado: (2021) -
The Asparaginyl Endopeptidase Legumain: An Emerging Therapeutic Target and Potential Biomarker for Alzheimer’s Disease
por: Song, Mingke
Publicado: (2022) -
One-step asparaginyl endopeptidase (OaAEP1)-based protein immobilization for single-molecule force spectroscopy
por: Ding, Xuan, et al.
Publicado: (2022) -
Asparaginyl endopeptidases: enzymology, applications and limitations
por: Tang, T. M. Simon, et al.
Publicado: (2021)